Receptor proteins for nongenomic actions of thyroid hormone

Paul J. Davis, Jack L. Leonard, Hung Yun Lin, Sandra Incerpi, Mary K. Luidens, Heng Yuan Tang, Shaker A. Mousa

研究成果: 雜誌貢獻文章

2 引文 斯高帕斯(Scopus)

摘要

Genomic actions of thyroid hormone require the intranuclear binding by nuclear thyroid hormone receptors (TRs) of 3,5,3’-triiodo-L-thyronine (T3). Nongenomic actions of the hormone have been described that are initiated at the plasma membrane, in cytoplasm or in the mitochondrion. These are complex processes associated with maintenance of the cytoskeleton, control of cell respiration, cell proliferation—including tumor cell proliferation and angiogenesis—and nervous system function. We briefly review here the nature of the proteins which are now appreciated to initiate nongenomic actions of the hormone when they bind T3 or L-thyroxine (T4). These receptor proteins for nongenomic effects include truncated isoforms of TRα, cytoplasmic intact TRβ, certain cytoplasmic enzymes and a structural protein of the plasma membrane, integrin αvβ3.
原文英語
頁(從 - 到)94-97
頁數4
期刊Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry
15
發行號1
出版狀態已發佈 - 七月 1 2015

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Pharmacology

指紋 深入研究「Receptor proteins for nongenomic actions of thyroid hormone」主題。共同形成了獨特的指紋。

  • 引用此

    Davis, P. J., Leonard, J. L., Lin, H. Y., Incerpi, S., Luidens, M. K., Tang, H. Y., & Mousa, S. A. (2015). Receptor proteins for nongenomic actions of thyroid hormone. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, 15(1), 94-97.